Table 2 Developing of blood and fecal parameters
Ulcerative colitis | Crohn's disease | |||
|---|---|---|---|---|
Lactulose (n= 7) | Control (n= 7) | Lactulose (n= 9) | Control (n= 8) | |
Immunoglobulin G (g/l)* | ||||
Before | 12.3 ± 1.3 | 14.0 ± 2.0 | 12.9 ± 4.6 | 11.8 ± 3.4 |
After | 12.9 ± 1.2 | 13.3 ± 2.0 | 11.8 ± 4.5 | 11.6 ± 4.1 |
Immunoglobulin A (g/l)* | ||||
Before | 3.0 ± 0.5 | 2.8 ± 0.4 | 4.6 ± 3.4 | 3.6 ± 1.1 |
After | 3.0 ± 0.7 | 2.3 ± 0.3 | 4.3 ± 3.4 | 3.6 ± 1.3 |
Immunoglobulin M (g/l)* | ||||
Before | 1.9 ± 0.2 | 2.4 ± 0.8 | 1.9 ± 1.7 | 1.7 ± 0.5 |
After | 2.1 ± 0.4 | 2.3 ± 0.7 | 1.9 ± 1.7 | 1.8 ± 1.0 |
Blood activity factor*,† | ||||
Before | -2.9 ± 1.9 | 2.9 ± 2.4 | -7.0 ± 3.1 | -4.7 ± 3.1 |
After | 5.4 ± 2.8 | 5.7 ± 1.2 | 1.3 ± 2.6‡ | 1.3 ± 2.0‡ |
Fecal α1-antitrypsine* | ||||
Before | 69.5 ± 17.6 | 56.8 ± 14.4 | 79.8 ± 9.9 | 66.5 ± 9.7 |
After | 27.8 ± 9.0 | 50.0 ± 12,7 | 55.3 ± 14.1 | 35.2 ± 11.4‡ |
Fecal pH* | ||||
Before | 6.4 ± 0.2 | 6.8 ± 0.1 | 6.8 ± 0.2 | 6.7 ± 0.7 |
After | 7.0 ± 0.3 | 6.8 ± 0.1 | 6.6 ± 0.4 | 6.6 ± 0.7 |